Private Ocean’s Sarepta Therapeutics SRPT Stock Holding History

Private Ocean’s Portfolio SRPT Stock Details SRPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-200	Closed	-$11K	–	509
2017 Q4	$11K	Buy	+200	New	+$10.6K	0.01%	227

Other funds holding SRPT

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

GGHC

Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

EAM

Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

Private Ocean's SRPT Position: Q1 2018 in Review

Private Ocean sold out of Sarepta Therapeutics (SRPT) in Q1 2018, closing a stake of 200 shares — an estimated $11K sold.

Private Ocean first reported a position in SRPT in Q4 2017 and held it in 1 quarter. The position peaked at $11K in Q4 2017. 269 funds tracked by Wall St. Rank hold SRPT as of Q1 2018.

Private Ocean reported no remaining Sarepta Therapeutics position as of Q1 2018 after selling out during the quarter.
Private Ocean sold 200 Sarepta Therapeutics shares in Q1 2018, an estimated $11K.
Private Ocean first reported a position in Sarepta Therapeutics in Q4 2017 and held it in 1 quarter.
Private Ocean's Sarepta Therapeutics position peaked at $11K in Q4 2017.
269 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q1 2018.

Based on Private Ocean's 13F filing for Q1 2018, filed 11 May 2018.